"El VHIO es un destacado centro oncológico integral de excelencia donde los científicos y doctores adoptan un modelo de investigación puramente traslacional, trabajando conjuntamente en equipos multidisciplinares para acelerar y avanzar en el campo de las terapias personalizadas y específicas contra el cáncer."

During the past decade, Vall d'Hebron Institut d'Oncologia (VHIO) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vall d'Hebron Institut d'Oncologia (VHIO)" are "Advanced Solid Tumor" (1 trials), "Advanced Urothelial Carcinoma" (1 trials), "Bladder Cancer" (1 trials), "Carcinoma" (1 trials) and "Colorectal Cancer Metastatic" (1 trials). Many other conditions were trialed in "Vall d'Hebron Institut d'Oncologia (VHIO)" in a lesser frequency.

Most popular intervention types in "Vall d'Hebron Institut d'Oncologia (VHIO)" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Futuximab" (1 trials), "Modotuximab" (1 trials), "Sym004" (1 trials) and "TYRA-300" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vall d'Hebron Institut d'Oncologia (VHIO)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Vall d'Hebron Institut d'Oncologia (VHIO)". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Vall d'Hebron Institut d'Oncologia (VHIO), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Vall d'Hebron Institut d'Oncologia (VHIO), 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".